| Spirig HealthCare AG - Tocilizumab Spirig HC 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 69925 | | 02 | | Tocilizumab Spirig HC 200 mg/10 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L04AC07 | | Tocilizumab | | 21.05.2025 | | |
|
| Composition |
| tocilizumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 10 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Tocilizumabum | 200mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Tocilizumabum | 200 mg |
| | | | Inactive agents |
|---|
| Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 009 | | 210.85 | 245.75 | A | SL | No | | 010 | 4 | | | A | | Yes |
|
